Evogene Ltd. (EVGN)
NASDAQ: EVGN · Real-Time Price · USD
1.560
-0.100 (-6.02%)
At close: Jan 27, 2025, 4:00 PM
1.500
-0.060 (-3.85%)
After-hours: Jan 27, 2025, 5:17 PM EST
Evogene Market Cap
Evogene has a market cap or net worth of $10.72 million as of January 27, 2025. Its market cap has decreased by -74.96% in one year.
Market Cap
10.72M
Enterprise Value
7.96M
1-Year Change
-74.96%
Ranking
Category
Stock Price
$1.56
Market Cap Chart
Since October 15, 2007, Evogene's market cap has decreased from $28.02M to $10.72M, a decrease of -61.72%. That is a compound annual growth rate of -5.40%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 707.21B |
| UnitedHealth Group | 490.06B |
| Novo Nordisk | 389.38B |
| Johnson & Johnson | 353.49B |
| AbbVie | 300.94B |
| Merck & Co. | 241.71B |
| Thermo Fisher Scientific | 219.87B |
| Abbott Laboratories | 216.86B |